Back to Research Hub
Certara, Inc.
CERT
$5.18-0.04 (-0.77%)
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access.
StreetsValue research for Certara, Inc. (CERT)
Members get the full report for Certara, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.